BriefApril 15, 2026 · 02:09 AM
Albertsons opioid settlement triggers $480.8 million quarterly loss
Albertsons reported a $480.8 million loss for the fourth quarter, driven by a $600 million impairment charge. The loss follows a settlement framework reached to resolve opioid-related claims brought by state, local, and tribal governments. Under the terms of the deal, Albertsons will pay $774 million over nine years. The lawsuits accused the company of failing to stop the overuse of prescription opioids in the US.
Finley Thatcher
corporate liabilitypharmacy litigationquarterly earnings
More Briefs
Apr 15
View All Briefs →Steve Aoki’s $30,000 Crypto Exit Signals the End of Celebrity-Driven Hype Cycles
Apr 15FinCEN Whistleblower Awards May Reach 30% of Sanctions
Apr 15A $9.99 monthly subscription is being pitched as entry to a $250 trillion AI revolution
Apr 15White House Signals Finality on CLARITY Act Crypto Regulation